PF-AtlasClinical Trials › NCT02929017

Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers

SUPPORT · Not specified

Registry ID
NCT02929017
Phase
Not specified
Status
Completed
Drug / intervention
SUPPORT
Sponsor
University of Pittsburgh
Start
2017-03-23
Enrollment
140
Locations
1

About this trial

Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention.

View NCT02929017 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT02929017 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.